» Articles » PMID: 3086002

Mechanisms of Macrophage Activation in Rheumatoid Arthritis: the Role of Gamma-interferon

Overview
Date 1986 Mar 1
PMID 3086002
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Gamma-interferon (gamma-IFN) is a potent inducer of surface expression of class II MHC molecules in vitro. Enhanced HLA-DR expression is a characteristic immuno-histological feature of rheumatoid joints. To assess the possible relevance of gamma-IFN to macrophage (M phi) activation in rheumatoid arthritis (RA) we investigated the spontaneous and mitogen-induced production of gamma-IFN by RA lymphocytes using a sensitive radioimmunoassay. Synovial fluids (SF) from a variety of inflammatory and non-inflammatory rheumatic diseases did not contain measurable amounts of IFN. RA lymphocytes from peripheral blood (PBL) and joints failed to show spontaneous gamma-IFN production. RA and control PBL were equally responsive to both mitogen stimulation and to the addition of exogenous interleukin 2 (IL-2) as control PBL. SF lymphocytes from RA patients showed a significantly decreased PHA-stimulated gamma-IFN production and this was in contrast to the SF lymphocytes from patients with other inflammatory joint diseases who showed significantly increased gamma-IFN production compared with matched PB lymphocytes. These results show that gamma-IFN production by peripheral blood and joint cells from patients with RA is normal and it remains to be established whether gamma-IFN is the factor responsible for the macrophage activation seen in the disease.

Citing Articles

Effect of pregnancy on collagen-induced arthritis in mice.

Waites G, Whyte A Clin Exp Immunol. 1987; 67(3):467-76.

PMID: 3608230 PMC: 1542636.


Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma.

Qin O, Yen-Lieberman B, Sapatnekar W, Youngman K, Kusugami K, Fiocchi C Dig Dis Sci. 1988; 33(12):1528-36.

PMID: 3143537 DOI: 10.1007/BF01535942.


Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma.

Lemmel E, Brackertz D, Franke M, Gaus W, Hartl P, Machalke K Rheumatol Int. 1988; 8(2):87-93.

PMID: 3135572 DOI: 10.1007/BF00271840.


Detection of activated T cell products in the rheumatoid joint using cDNA probes to Interleukin-2 (IL-2) IL-2 receptor and IFN-gamma.

Buchan G, Barrett K, Fujita T, Taniguchi T, Maini R, Feldmann M Clin Exp Immunol. 1988; 71(2):295-301.

PMID: 3127092 PMC: 1541449.


Quantification of macrophage cell surface molecules in rheumatoid arthritis.

Hessian P, Highton J, Palmer D Clin Exp Immunol. 1989; 77(1):47-51.

PMID: 2527651 PMC: 1541930.


References
1.
Dobloug J, Forre O, Kvien T, Egeland T, DeGre M . Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Ann Rheum Dis. 1982; 41(5):490-4. PMC: 1001029. DOI: 10.1136/ard.41.5.490. View

2.
OMalley J, Sheedy D, Grossmayer B, Ozer H . Identification of the T cell subset that produces human gamma interferon. J Immunol. 1982; 128(6):2522-6. View

3.
Hasler F, Bluestein H, Zvaifler N, Epstein L . Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation. J Exp Med. 1983; 157(1):173-88. PMC: 2186886. DOI: 10.1084/jem.157.1.173. View

4.
Fontana A, Hengartner H, Weber E, Fehr K, Grob P, Cohen G . Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int. 1982; 2(2):49-53. DOI: 10.1007/BF00541245. View

5.
Basham T, Merigan T . Recombinant interferon-gamma increases HLA-DR synthesis and expression. J Immunol. 1983; 130(4):1492-4. View